Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$365M |
| 2 |
Global Payments
GPN
|
+$250M |
| 3 |
NiSource
NI
|
+$109M |
| 4 |
Constellation Brands
STZ
|
+$107M |
| 5 |
Xcel Energy
XEL
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$95.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$89.4M |
| 3 |
ExxonMobil
XOM
|
+$84.7M |
| 4 |
Southern Company
SO
|
+$79.2M |
| 5 |
Emerson Electric
EMR
|
+$61.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.26% |
| 2 | Industrials | 7.84% |
| 3 | Utilities | 7.6% |
| 4 | Healthcare | 5.4% |
| 5 | Real Estate | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTTR
1126
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $359K | ﹤0.01% |
+133,296
| New | +$321K |
|
1127
Medallion Financial
MFIN
$267M
| $356K | ﹤0.01% |
+36,182
| New | +$301K |
|
1128
Immunome
IMNM
$3.18B
| $355K | ﹤0.01% |
+33,142
| New | +$276K |
|
1129
Alarm.com
ALRM
$2.83B
| $353K | ﹤0.01% |
+5,455
| New | +$313K |
|
1130
Kearny Financial
KRNY
$618M
| $353K | ﹤0.01% |
39,298
+411
| +1% | +$3.19K |
|
1131
Anika Therapeutics
ANIK
$286M
| $352K | ﹤0.01% |
+15,533
| New | +$321K |
|
1132
SLR Investment Corp
SLRC
$693M
| $352K | ﹤0.01% |
+23,392
| New | +$349K |
|
1133
ZIM Integrated Shipping Services
ZIM
$3.42B
| $351K | ﹤0.01% |
+35,519
| New | +$298K |
|
1134
Advanced Drainage Systems
WMS
$10.6B
| $350K | ﹤0.01% |
2,488
-21,522
| -90% | -$2.59M |
|
1135
Fulcrum Therapeutics
FULC
$293M
| $349K | ﹤0.01% |
+51,664
| New | +$229K |
|
1136
Quanex
NX
$916M
| $348K | ﹤0.01% |
+11,398
| New | +$336K |
|
1137
Foster
FSTR
$394M
| $346K | ﹤0.01% |
+15,752
| New | +$311K |
|
|
MZTI
1138
The Marzetti Company
MZTI
$3.17B
| $345K | ﹤0.01% |
+2,074
| New | +$348K |
|
1139
EXL Service
EXLS
$5.71B
| $343K | ﹤0.01% |
11,104
-40,479
| -78% | -$1.15M |
|
1140
GCM Grosvenor
GCMG
$834M
| $343K | ﹤0.01% |
+38,315
| New | +$319K |
|
1141
Planet Labs
PL
$7.69B
| $342K | ﹤0.01% |
138,547
+28,516
| +26% | +$67.5K |
|
1142
Sphere Entertainment
SPHR
$5.65B
| $340K | ﹤0.01% |
+10,018
| New | +$349K |
|
1143
MarineMax
HZO
$1.15B
| $338K | ﹤0.01% |
+8,686
| New | +$275K |
|
1144
MillerKnoll
MLKN
$1.58B
| $336K | ﹤0.01% |
+12,605
| New | +$322K |
|
1145
Travere Therapeutics
TVTX
$6.15B
| $336K | ﹤0.01% |
+37,419
| New | +$272K |
|
|
LGTY
1146
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $336K | ﹤0.01% |
29,760
+18,275
| +159% | +$196K |
|
|
AAN
1147
DELISTED
The Aaron's Company Inc
AAN
| $336K | ﹤0.01% |
30,851
-25,113
| -45% | -$233K |
|
|
VERV
1148
DELISTED
Verve Therapeutics
VERV
| $335K | ﹤0.01% |
24,036
-208,584
| -90% | -$2.59M |
|
|
BRDG
1149
DELISTED
Bridge Investment Group
BRDG
| $334K | ﹤0.01% |
+34,103
| New | +$276K |
|
1150
Identive
INVE
$69.3M
| $332K | ﹤0.01% |
+40,301
| New | +$284K |
|
Similar funds
Michael Gelband's Q4 2023 Portfolio in Review
As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.
On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.
- Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
- Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
- Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
- Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
- Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
- Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
- Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.